Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3. This reflects a minor update to the site’s interface/versioning shown on the page rather than changes to the study data.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe ClinicalTrials.gov page now displays a newer site revision/version number (v3.5.3 instead of v3.5.2) while the underlying record history content remains the same.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check74 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a new revision entry v3.4.3 and removed the previous revision v3.4.2 from the history.SummaryDifference0.1%

- Check96 days agoChange DetectedVisual/layout updates to the Record History page; core study data and identifiers appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.